Status:
COMPLETED
Intravenous Remifentanil for Labor Analgesia
Lead Sponsor:
Nanjing Medical University
Collaborating Sponsors:
HRSA/Maternal and Child Health Bureau
Conditions:
Labor Pain
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
Labor analgesia is an essential health caring procedure for women. However, epidural analgesia cannot be performed on all subjects for different contraindications, such as lower platelet counter, back...
Eligibility Criteria
Inclusion
- Nulliparous women
- \> 18 years and \< 45 years
- Spontaneous labor
- Analgesia request
- Epidural puncture contraindications
- Tendency of bleeding
Exclusion
- Allergy to opioids, a history of the use of centrally-acting drugs of any sort, chronic pain and psychiatric diseases records
- Participants younger than 18 years or older than 45 years
- Those who were not willing to or could not finish the whole study at any time
- Using or used in the past 14 days of the monoamine oxidase inhibitors
- Alcohol addictive or narcotic dependent patients were excluded for their influence on the analgesic efficacy of the epidural analgesics
- Subjects with a nonvertex presentation or scheduled induction of labor
- Cervical dilation was 5.0cm or greater before performing epidural puncture and catheterization
- Diagnosed diabetes mellitus and pregnancy-induced hypertension
- Twin gestation and breech presentation
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00710086
Start Date
July 1 2008
End Date
September 1 2009
Last Update
September 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanjing Maternal and Child Health Care Hospital
Nanjing, Jiangsu, China, 210004